Skip to main content

Secondary navigation

Contact Us

Home
Search Portfolio
Reports and Publications
About Portfolio

Breadcrumb

Home
Development of antisense oligonucleotides that enhance sIL7R as novel cancer immunotherapy

Development of antisense oligonucleotides that enhance sIL7R as novel cancer immunotherapy

Project Number

1 R43 CA257108-01A1

Agency/Funding Organization

NCI

Funding Year

2021

View Full Project Details for Development of antisense oligonucleotides that enhance sIL7R as novel cancer immunotherapy

Footer Topic Menu 2

Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health
U.S. Department of Health and Human Services

Footer topic menu

Accessibility
Disclaimer
FOIA
Privacy Notice

The Interagency Rehabilitation and Disability Research Portfolio (IRAD), identified by National Institutes of Health Library, is free of known copyright restrictions. Site created and maintained by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the NIH Library as a government created work. This website is marked Public Domain under Creative Commons. Vulnerability Disclosure Policy. Data provided by NIH for this website is not official reporting. For official reporting categories, please visit NIH RePORTER.